Apple is increasingly focusing on building its own devices and expanding its ecosystem by taking steps towards a more native experience for users and relying less on third-party accessories. While the Cupertino-based tech giant's HomePod and AppleTV have left quite the mark in the smart home category, it generally relies more on outsourcing cameras and other hardware for smart homes. Now, a new report suggests that the company intends to create a fully integrated experience by developing its own smart home accessories. Gurman hints about Apple working on making smart home products like security cameras for a more integrated experience […]
We’re continuing our Best of Black Friday posts today with a look at the best current deals on power stations and their respective bundle options. Folks across the country and beyond have been steadily investing more and more in the industry for a vari...
Blizzard has announced that two decades after its release, World of Warcraft is finally going to let players build a home and live in it. The feature has long been requested by WoW players and now it’s finally coming in the game’s next expansion.Read m...
Guild Wars 2: Janthir Wilds will receive the Godspawn update, adding a new 50-player boss battle, a new 10-player raid, and a legendary spear. Guild Wars 2: Janthir Wilds is getting the first major update "Godspawn" on November 19th, expanding the story with new story chapters The MMORPG Guild Wars 2 by ArenaNet is receiving its first major update for the Janthir Wilds expansion soon. It's the first of three major updates, and it'll land on November 19. The update will add new content to the game for the players. The Janthir Wilds expansion DLC was released in August this year, […]
With the launch of dedicated Jim Cramer-tracking ETFs, there was widespread hope for a period of time that the CNBC host would become more circumspect in issuing his infamous investment recommendations, ones that had spawned an entire genre of contrarian investment style, based on Cramer's well-tested ability to echo the market's consensus view. Alas, with the shuttering of the Long Cramer Tracker ETF (LJIM) ETF back in August after notching just 2.2 percent gains for the year, that hope has all but disappeared. Interestingly, the Short Jim Cramer ETF (SJIM) by Tuttle Capital Management is still functional, having notched year-to-date […]
Apart from having a reputation for possessing Midas' legendary touch of gold for having transformed almost all of his previous initiatives into profit-making enterprises, Elon Musk also excels in providing inspiration for a host of meme coins, most of which dissipate within a few weeks after capitalizing on the initial frenzy. Dogecoin (DOGE) and STOPELON tokens serve as an apt emblem of this phenomenon. Now, just a few days after the launch of xAI's Grok LLM, we have another meme token, quite imaginatively (sarc) named the GROK coin. Ethereum allows virtually everyone to issue an ERC-20 token that takes advantage […]
According to Bitcoin's bulls, the time to vanquish crypto detractors for good is now finally within reach, aided by the growing clarity on the regulatory front and boosted by accelerating institutional adoption. For months, the bears held sway over the broader narrative, harping on Bitcoin's price weakness to show that the world's premier cryptocurrency had no utility whatsoever in the greater scheme of things. Well, just look at how the tables have turned now! At the time of writing, Bitcoin is up an astonishing 38 percent over the past month. So far this year, the world's preeminent cryptocurrency is up […]
A price war waged by big pharma usually works in the favor of consumers, in the short term at least, or until the victor captures the market and establishes a monopoly. Eli Lilly and Company unveiled its opening gambit earlier this week by pricing its GLP-1 weight loss drug at a substantial discount to a competing offering by Novo Nordisk. The Danish pharmaceutical giant has now responded by hyping up the results of a critical trial. Glucagon-Like Peptide-1, or GLP-1 for short, plays an important role in regulating hunger. This hormone forms the bedrock of Novo Nordisk's Ozempic and Wegovy […]
SpaceX can launch the Starship test flight as soon as next week should it receive regulatory approval, according to a fresh social media post from the company. Starship, the world's largest rocket, is currently being developed in Boca Chica, Texas, and just like its first test flight attempt in April, SpaceX is ready to launch pending regulatory approval. According to the company's post on the social media platform X (formerly Twitter), it can launch Starship as soon as on November 17th. SpaceX's latest estimate for Starship follows an uptick in development activities in Texas that have seen it test the […]
NASA and SpaceX have launched the agency's latest cargo supply mission to the International Space Station (ISS). The launch is part of the CRS-29 mission and it sent thousands of pounds of cargo to the ISS. It marks SpaceX's 81st launch of the year, leaving the firm tantalizingly close to its aim of launching 100 missions to space in 2023. SpaceX has rapidly scaled up its payload cadence as of late, courtesy of its Starlink satellite internet constellation. At the same time, the firm is also building its Starship rocket in Texas, and right now, it is waiting for regulatory […]
With Trump's net worth having grown by around $400 million since leaving office, or around 4 times the current net value of Trump Media and Technology Group (TMTG), the fate of the battered merger agreement between TMTG and the SPAC Digital World (DWAC) is of scant importance to the former US President in the greater scheme of things, especially as the $1 billion windfall from the deal has all but evaporated. Nonetheless, TMTG's Truth Social platform can still serve an important purpose should Trump win the US Presidency in 2024, hence the unabated interest in the fate of this marooned […]
SpaceX and NASA are ready to fly the space agency's 29th cargo mission to the International Space Station (ISS) with the Cargo Dragon spacecraft. The mission, CRS-29, will launch on the Falcon 9 rocket from Florida tomorrow evening after its launch readiness review ended favorably earlier today. SpaceX has launched more than three dozen crewed and cargo missions with its Dragon spacecraft, with tomorrow's mission being initially set to fly at the end of last week. The reason for the delay is as common as it can get, with SpaceX detecting faulty valves on this Dragon vehicle, which is set […]
The GLP-1 phenomenon is truly on the role, particularly in the US. Now, Eli Lilly and Company has moved one step closer to realizing the $100 billion annual sales potential for GLP-1 drugs by winning a key FDA approval. Eli Lilly and Company's Mounjaro (Tirzepatide) injections treat type-2 diabetes as well as obesity by targeting two hormones – Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) – to control blood sugar levels. Retatutide, another offering by Eli Lilly and Company, is currently undergoing clinical trials and supposedly offers superior results by targeting three different hunger-regulating hormones: GLP-1, GIP, and Glucagon. As […]
The EV bubble has most certainly popped and the time of reckoning is now upon once high-flying stocks as they contend with the ground realities of a full-fledged price war by Tesla amid muted demand for electric vehicles. Fisker (NYSE: FSR) stock was briefly a darling of the market back in 2021. Now, it is plumbing all-time lows. $FSR just delayed earnings that were set to be released right NOW because the Chief Accounting Officer “departed” on Oct 27th The CTO also resigned on Oct 30th Seems like the whole c-suite that isn’t married to the CEO jumped ship before […]
The stock market is currently undergoing a thematic shift, one that favors weight loss drug manufacturers such as Eli Lilly and Company (LLY) over fitness-related names such as Peloton (PTON). Akin to a stone rolling down a hill, gathering momentum with each turn, such shifts represent generational wealth-making opportunities on the back of accelerating trends, as was witnessed when Netflix ushered in the age of content streaming or when Tesla popularized EVs as a crucial ingredient in combatting climate change. Eli Lilly and Company (LLY) Vs. Peloton (PTON) Eli Lilly and Company's Mounjaro injections treat type-2 diabetes as well as […]
After vanquishing for good a supposed "Tesla Killer," Elon Musk is taking a well-deserved victory lap of sorts today as Lucid Group has finally yielded to the inevitable. That must have been a bitter pill to swallow 😂 — Elon Musk (@elonmusk) November 6, 2023 To wit, Lucid Group announced today that it was adopting Tesla's North American Charging Standard (NACS) for its EVs, effective from 2025 onwards. To this, Elon Musk wrote on X: "That must have been a bitter pill to swallow." Bear in mind that Lucid Group's CEO, Peter Rawlinson, is widely credited with designing Tesla's Model […]
With the launch of dedicated Jim Cramer-tracking ETFs, there was widespread hope for a period of time that the CNBC host would become more circumspect in issuing his infamous investment recommendations, ones that had spawned an entire genre of contrarian investment style, based on Cramer's well-tested ability to echo the market's consensus view. Alas, with the shuttering of the Long Cramer Tracker ETF (LJIM) ETF back in August after notching just 2.2 percent gains for the year, that hope has all but disappeared. Interestingly, the Short Jim Cramer ETF (SJIM) by Tuttle Capital Management is still functional, having notched year-to-date […]
Apart from having a reputation for possessing Midas' legendary touch of gold for having transformed almost all of his previous initiatives into profit-making enterprises, Elon Musk also excels in providing inspiration for a host of meme coins, most of which dissipate within a few weeks after capitalizing on the initial frenzy. Dogecoin (DOGE) and STOPELON tokens serve as an apt emblem of this phenomenon. Now, just a few days after the launch of xAI's Grok LLM, we have another meme token, quite imaginatively (sarc) named the GROK coin. Ethereum allows virtually everyone to issue an ERC-20 token that takes advantage […]
According to Bitcoin's bulls, the time to vanquish crypto detractors for good is now finally within reach, aided by the growing clarity on the regulatory front and boosted by accelerating institutional adoption. For months, the bears held sway over the broader narrative, harping on Bitcoin's price weakness to show that the world's premier cryptocurrency had no utility whatsoever in the greater scheme of things. Well, just look at how the tables have turned now! At the time of writing, Bitcoin is up an astonishing 38 percent over the past month. So far this year, the world's preeminent cryptocurrency is up […]
A price war waged by big pharma usually works in the favor of consumers, in the short term at least, or until the victor captures the market and establishes a monopoly. Eli Lilly and Company unveiled its opening gambit earlier this week by pricing its GLP-1 weight loss drug at a substantial discount to a competing offering by Novo Nordisk. The Danish pharmaceutical giant has now responded by hyping up the results of a critical trial. Glucagon-Like Peptide-1, or GLP-1 for short, plays an important role in regulating hunger. This hormone forms the bedrock of Novo Nordisk's Ozempic and Wegovy […]
SpaceX can launch the Starship test flight as soon as next week should it receive regulatory approval, according to a fresh social media post from the company. Starship, the world's largest rocket, is currently being developed in Boca Chica, Texas, and just like its first test flight attempt in April, SpaceX is ready to launch pending regulatory approval. According to the company's post on the social media platform X (formerly Twitter), it can launch Starship as soon as on November 17th. SpaceX's latest estimate for Starship follows an uptick in development activities in Texas that have seen it test the […]
NASA and SpaceX have launched the agency's latest cargo supply mission to the International Space Station (ISS). The launch is part of the CRS-29 mission and it sent thousands of pounds of cargo to the ISS. It marks SpaceX's 81st launch of the year, leaving the firm tantalizingly close to its aim of launching 100 missions to space in 2023. SpaceX has rapidly scaled up its payload cadence as of late, courtesy of its Starlink satellite internet constellation. At the same time, the firm is also building its Starship rocket in Texas, and right now, it is waiting for regulatory […]
With Trump's net worth having grown by around $400 million since leaving office, or around 4 times the current net value of Trump Media and Technology Group (TMTG), the fate of the battered merger agreement between TMTG and the SPAC Digital World (DWAC) is of scant importance to the former US President in the greater scheme of things, especially as the $1 billion windfall from the deal has all but evaporated. Nonetheless, TMTG's Truth Social platform can still serve an important purpose should Trump win the US Presidency in 2024, hence the unabated interest in the fate of this marooned […]
SpaceX and NASA are ready to fly the space agency's 29th cargo mission to the International Space Station (ISS) with the Cargo Dragon spacecraft. The mission, CRS-29, will launch on the Falcon 9 rocket from Florida tomorrow evening after its launch readiness review ended favorably earlier today. SpaceX has launched more than three dozen crewed and cargo missions with its Dragon spacecraft, with tomorrow's mission being initially set to fly at the end of last week. The reason for the delay is as common as it can get, with SpaceX detecting faulty valves on this Dragon vehicle, which is set […]
The GLP-1 phenomenon is truly on the role, particularly in the US. Now, Eli Lilly and Company has moved one step closer to realizing the $100 billion annual sales potential for GLP-1 drugs by winning a key FDA approval. Eli Lilly and Company's Mounjaro (Tirzepatide) injections treat type-2 diabetes as well as obesity by targeting two hormones – Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) – to control blood sugar levels. Retatutide, another offering by Eli Lilly and Company, is currently undergoing clinical trials and supposedly offers superior results by targeting three different hunger-regulating hormones: GLP-1, GIP, and Glucagon. As […]
The EV bubble has most certainly popped and the time of reckoning is now upon once high-flying stocks as they contend with the ground realities of a full-fledged price war by Tesla amid muted demand for electric vehicles. Fisker (NYSE: FSR) stock was briefly a darling of the market back in 2021. Now, it is plumbing all-time lows. $FSR just delayed earnings that were set to be released right NOW because the Chief Accounting Officer “departed” on Oct 27th The CTO also resigned on Oct 30th Seems like the whole c-suite that isn’t married to the CEO jumped ship before […]
The stock market is currently undergoing a thematic shift, one that favors weight loss drug manufacturers such as Eli Lilly and Company (LLY) over fitness-related names such as Peloton (PTON). Akin to a stone rolling down a hill, gathering momentum with each turn, such shifts represent generational wealth-making opportunities on the back of accelerating trends, as was witnessed when Netflix ushered in the age of content streaming or when Tesla popularized EVs as a crucial ingredient in combatting climate change. Eli Lilly and Company (LLY) Vs. Peloton (PTON) Eli Lilly and Company's Mounjaro injections treat type-2 diabetes as well as […]
After vanquishing for good a supposed "Tesla Killer," Elon Musk is taking a well-deserved victory lap of sorts today as Lucid Group has finally yielded to the inevitable. That must have been a bitter pill to swallow 😂 — Elon Musk (@elonmusk) November 6, 2023 To wit, Lucid Group announced today that it was adopting Tesla's North American Charging Standard (NACS) for its EVs, effective from 2025 onwards. To this, Elon Musk wrote on X: "That must have been a bitter pill to swallow." Bear in mind that Lucid Group's CEO, Peter Rawlinson, is widely credited with designing Tesla's Model […]